» Authors » Wolfram H Gerlich

Wolfram H Gerlich

Explore the profile of Wolfram H Gerlich including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 66
Citations 1482
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gerlich W
Virus Genes . 2024 Feb; 60(2):240-242. PMID: 38353809
No abstract available.
2.
Lehmann F, Slanina H, Roderfeld M, Roeb E, Trebicka J, Ziebuhr J, et al.
Viruses . 2023 Apr; 15(4). PMID: 37112819
Chronic hepatitis B virus (HBV) infection is a global health threat. Mutations in the surface antigen of HBV (HBsAg) may alter its antigenicity, infectivity, and transmissibility. A patient positive for...
3.
Gerlich W
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz . 2022 Jan; 65(2):170-182. PMID: 35015108
The first experimental vaccinations against hepatitis B virus (HBV) were performed in 1970, even before the nature of the administered "Australia antigen" was known. Soon, it was realized that this...
4.
Glebe D, Lehmann F, Goldmann N, Giese A, Hida Y, Gerlich W, et al.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz . 2022 Jan; 65(2):220-227. PMID: 35015105
The National Reference Center (NRC) for hepatitis B viruses (HBV) and hepatitis D viruses (HDV) has been located at the Institute of Medical Virology of the Justus Liebig University (JLU)...
5.
6.
Safadi R, Khoury T, Saed N, Hakim M, Jamalia J, Nijim Y, et al.
Vaccines (Basel) . 2021 Apr; 9(4). PMID: 33915943
Peripartum transmission of hepatitis B virus (HBV) from an infected mother to the child can be prevented in most but not all cases by immediate vaccination of the newborn. The...
7.
Gerlich W, Glebe D
Virus Genes . 2020 Nov; 56(6):675-676. PMID: 33151446
No abstract available.
8.
Gerlich W
EBioMedicine . 2020 Sep; 60:102998. PMID: 32977164
No abstract available.
9.
Pfefferkorn M, Schott T, Bohm S, Deichsel D, Felkel C, Gerlich W, et al.
J Hepatol . 2020 Sep; 74(2):283-292. PMID: 32931877
Background & Aims: During treatment of chronic HBV infections, loss or seroconversion of the HBV surface antigen (HBsAg) is considered a functional cure. HBsAg consists of the large (LHBs), middle...
10.
Gerlich W
Lancet Infect Dis . 2020 Aug; 21(1):6-8. PMID: 32805202
No abstract available.